NeuroSense Therapeutics L...

NASDAQ: NRSNW · Real-Time Price · USD
0.69
0.00 (0.00%)
At close: Aug 15, 2025, 3:20 PM
0.75
8.70%
After-hours: Aug 15, 2025, 04:00 PM EDT

NeuroSense Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.38M 2.64M 3.54M 11.06M
Short-Term Investments
n/a n/a 3.55M n/a
Long-Term Investments
n/a n/a 23K n/a
Other Long-Term Assets
23K 31K n/a n/a
Receivables
164K 166K 131K 178K
Inventory
n/a n/a -3.68M -178K
Other Current Assets
35K 40K 36K 39K
Total Current Assets
4.4M 2.92M 7.38M 11.41M
Property-Plant & Equipment
150K 238K 306K 19K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
173K 269K 329K 19K
Total Assets
4.58M 3.18M 7.71M 11.43M
Account Payables
1.16M 1.46M 498K 39K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
261K 614K 413K 443K
Total Current Liabilities
1.99M 3.46M 1.73M 597K
Long-Term Debt
n/a n/a 147K n/a
Other Long-Term Liabilities
n/a 1.52M 71K n/a
Total Long-Term Liabilities
n/a 1.59M 365K 1.83M
Total Liabilities
1.99M 4.94M 2.09M 2.42M
Total Debt
73K 142K 211K 1.83M
Common Stock
n/a n/a n/a n/a
Retained Earnings
-36.66M -26.12M -20.79M -8.45M
Comprehensive Income
n/a n/a 26.41M 17.45M
Shareholders Equity
2.58M -1.87M 5.62M 9.01M
Total Investments
n/a 22K 3.55M n/a